Identification of differentially expressed myeloma-specific pathways in the absence of VLA-4

被引：0
|
作者：
Hathi, Deep K. [1 ]
Chanswangphuwana, Chantiya [1 ]
Rettig, Michael P. [1 ]
Achilefu, Samuel [1 ]
DiPersio, John F. [1 ]
Shokeen, Monica [1 ]
机构：
[1] Washington Univ, St Louis, MO 63110 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2525
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2525
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Identification of differentially expressed genes, pathways, and immune infiltration in diabetes
    Liang, Ying
    Wei, Shuxiang
    Peng, Xing
    Feng, Qiling
    Li, Lingling
    Liang, Diefei
    Wu, Hongshi
    Zhang, Xiaoyun
    Huang, Chulin
    Lin, Yongqing
    CLINICS, 2024, 79
  • [22] Identification of myeloma-specific T cell receptors by functional single cell interaction analyses
    Wagner, Tim R.
    Boga, Eren
    Schmidt, Patrick
    Osen, Wolfram
    Platten, Michael
    Goldschmidt, Hartmut
    Raab, Marc S.
    Friedrich, Mirco J.
    Eichmuller, Stefan B.
    CANCER RESEARCH, 2023, 83 (07)
  • [23] Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists
    Doherty, GA
    Yang, GX
    Borges, E
    Chang, LL
    MacCoss, M
    Tong, S
    Kidambi, U
    Egger, LA
    McCauley, E
    Van Riper, G
    Mumford, RA
    Schmidt, JA
    Hagmann, WK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (11) : 1501 - 1505
  • [24] Upregulation of integrin VLA-4 is associated with low level drug resistance in human myeloma cells.
    Damiano, J
    Cress, AE
    Dalton, WS
    BLOOD, 1997, 90 (10) : 2206 - 2206
  • [25] Activation status and function of the VLA-4 (alpha 4 beta 1) integrin expressed on human melanoma cell lines
    Saini, A
    Seller, Z
    Davies, D
    Marshall, JF
    Hart, IR
    INTERNATIONAL JOURNAL OF CANCER, 1997, 73 (02) : 264 - 270
  • [26] Identification of novel myeloma-specific peptides able to generate specific and effective cytotoxic T lymphocytes: Potential therapeutic application in multiple myeloma
    Bae, J
    Yu-Tzu, T
    Neri, P
    Carrasco, R
    Sukhdeo, K
    Prabhala, R
    Anderson, KC
    Munshi, NC
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 610 - 611
  • [27] Identification of potent, selective VLA-4 antagonists as chemical tools to answer biological questions.
    Huryn, DM
    Ashwell, S
    Baudy, RB
    Dressen, DB
    Freedman, SB
    Grant, FS
    Kennedy, J
    Konradi, AW
    Kreft, A
    Lombardo, LJ
    Pleiss, MA
    Sarantakis, D
    Yednock, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U936 - U936
  • [28] The identification of human cardiac-specific differentially expressed genes
    Steenman, M
    Le Cunff, M
    Potier, M
    Scheidler, S
    Léger, J
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2000, 78 (03): : B16 - B16
  • [29] Focused library approach for identification of new N-acylphenylalanines as VCAM/VLA-4 antagonists
    Chen, L
    Trilles, R
    Miklowski, D
    Huang, TN
    Fry, D
    Campbell, R
    Rowan, K
    Schwinge, V
    Tilley, JW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (12) : 1679 - 1682
  • [30] Identification of CD8+ T-cell epitope from multiple myeloma-specific antigen AKAP4
    Ma, Ning
    Liu, Huihui
    Zhang, Yang
    Liu, Wei
    Liang, Zeyin
    Wang, Qian
    Sun, Yuhua
    Wang, Lihong
    Li, Yuan
    Ren, Hanyun
    Dong, Yujun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345